Search for: "The Adam Group Inc."
Results 161 - 180
of 767
Sort by Relevance
|
Sort by Date
17 Mar 2020, 1:32 pm
Lidocaine HCl Topical Solution 4%, 50ml, has been recalled by Teligent Pharma, Inc. due to super potency. [read post]
16 Mar 2020, 3:05 am
R v Adams (Northern Ireland), heard 19 November 2019. [read post]
15 Mar 2020, 8:59 pm
A Private Duty in Pandemics, and Insurance Considerations In Adam, Abudu v. [read post]
9 Mar 2020, 4:11 pm
Pepper Hilton Hotels Black & Decker Dunlop Tires IBM Braum’s Inc. [read post]
9 Mar 2020, 2:49 am
R v Adams (Northern Ireland), heard 19 November 2019. [read post]
25 Feb 2020, 4:58 am
Adam Miller, CEO and founder of Cornerstone, says of the acquisition: “Saba and Cornerstone have always shared a passion for people development, and together we can accomplish great things. [read post]
24 Feb 2020, 1:55 am
R v Adams (Northern Ireland), heard 19 November 2019. [read post]
20 Feb 2020, 6:33 am
There, the Supreme Court clarified, in contrast to its 2011 decision in Janus Capital Group, Inc. v. [read post]
17 Feb 2020, 2:13 am
R v Adams (Northern Ireland), heard 19 November 2019. [read post]
13 Feb 2020, 5:29 pm
Apple, Inc., 870 F.3d 867 (9th Cir. 2017). [read post]
11 Feb 2020, 4:04 am
Fossil, Inc. [read post]
10 Feb 2020, 1:31 am
R v Adams (Northern Ireland), heard 19 November 2019. [read post]
3 Feb 2020, 4:33 am
Healthworks Medical Group of Ohio, Inc. [read post]
24 Jan 2020, 3:49 am
At The National Law Review, Eric Fisher writes that the court’s recent decision in Ritzen Group Inc. v. [read post]
23 Jan 2020, 11:41 am
Public Interest Research Group Education Fund, Inc. [read post]
22 Jan 2020, 1:01 pm
See id.; see also Pro Axess, Inc. v. [read post]
19 Jan 2020, 4:52 pm
Congratulations to Adam Speker of 5RB who was appointed as a QC in the recently published list. [read post]
16 Jan 2020, 4:05 am
” At Final Decisions, Bryan Lammon discusses Tuesday’s opinion in Ritzen Group Inc. v. [read post]
15 Jan 2020, 4:11 am
In Ritzen Group Inc. v. [read post]
9 Jan 2020, 11:43 am
Reckitt — Multiple whistleblowers received awards from the $700 million Reckitt Benckiser Group plc paid to resolve allegations it violated the False Claims Act relating to its marketing and sale of its opioid addiction treatment drug Suboxone (through its then-subsidiary Indivior Inc.). [read post]
